Alain Chevallier

Partner, Life Sciences

Alain Chevallier has extensive experience of the pharmaceutical industry to which he has devoted his entire professional career. He spent 30 years in the Sanofi Group, during which he held various positions of GM of subsidiaries abroad (Latin America, Japan) and finance departments as Chief Financial Officer of Aventis Pharma SA and Sanofi Aventis France.

For the past ten years, Alain has dedicated his time to the development of young innovative companies in the field of biotechnology.

In 2008, Alain co-founded Splicos SAS with Truffle Capital. He led as Chief Financial Officer the IPO of Deinove in 2010, of ABIVAX in 2015 and as Chairman of the Board the IPO of Carbios in 2013.

Alain Chevallier is a graduate of HEC.

First FinTech Closing
On the 15th of November 2017, Truffle has successfully completed the first closing of its institutional fund Truffle Financial Innovation Fund.
Premier closing FinTech
Le 15/11/2017, Truffle réalise le premier closing de son fonds institutionnel Truffle Financial Innovation Fund.
Premier closing FinTech
Le 15/11/2017, Truffle réalise le premier closing de son fonds institutionnel Truffle Financial Innovation Fund.